Mereo BioPharma Group plc Operating Lease, Liability in USD from Q4 2023 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Mereo BioPharma Group plc quarterly Operating Lease, Liability history and growth rate from Q4 2023 to Q3 2025.
Mereo BioPharma Group plc Operating Lease, Liability for the quarter ending September 30, 2025 was $397K, a 64.9% decline year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Growth (%)

Mereo BioPharma Group plc Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$397K	-$733K	-64.9%	Sep 30, 2025	10-Q	2025-11-10
Q2 2025	$601K	-$630K	-51.2%	Jun 30, 2025	10-Q	2025-08-12
Q1 2025	$747K	-$642K	-46.2%	Mar 31, 2025	10-Q	2025-05-13
Q4 2024	$894K	-$664K	-42.6%	Dec 31, 2024	10-K	2025-03-26
Q3 2024	$1.13M			Sep 30, 2024	10-Q	2024-11-12
Q2 2024	$1.23M			Jun 30, 2024	10-Q	2024-08-13
Q1 2024	$1.39M			Mar 31, 2024	10-Q	2024-05-15
Q4 2023	$1.56M			Dec 31, 2023	10-K	2024-03-27

* An asterisk sign (*) next to the value indicates that the value is likely invalid.